Recombinant CTLA4 antibody
Quick Overview for Recombinant CTLA4 antibody (ABIN7127437)
Target
See all CTLA4 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Human
-
Purification
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human CTLA4 (CD152)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Alternative Name
- CTLA4
-
Background
-
Background: Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.
Aliases: Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152), CTLA4, CD152
-
UniProt
- P16410
-
Pathways
- Cancer Immune Checkpoints
Target
-